BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16562984)

  • 1. Making "real" molecules in virtual space.
    Pirok G; Maté N; Varga J; Szegezdi J; Vargyas M; Dórant S; Csizmadia F
    J Chem Inf Model; 2006; 46(2):563-8. PubMed ID: 16562984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLEVER: pipeline for designing in silico chemical libraries.
    Song CM; Bernardo PH; Chai CL; Tong JC
    J Mol Graph Model; 2009 Jan; 27(5):578-83. PubMed ID: 18986817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of focused and restrained subsets from extremely large virtual libraries.
    Jamois EA; Lin CT; Waldman M
    J Mol Graph Model; 2003 Nov; 22(2):141-9. PubMed ID: 12932785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarity searching and scaffold hopping in synthetically accessible combinatorial chemistry spaces.
    Boehm M; Wu TY; Claussen H; Lemmen C
    J Med Chem; 2008 Apr; 51(8):2468-80. PubMed ID: 18380426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEAP into the Pfizer Global Virtual Library (PGVL) space: creation of readily synthesizable design ideas automatically.
    Hu Q; Peng Z; Kostrowicki J; Kuki A
    Methods Mol Biol; 2011; 685():253-76. PubMed ID: 20981528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGVL Hub: An integrated desktop tool for medicinal chemists to streamline design and synthesis of chemical libraries and singleton compounds.
    Peng Z; Yang B; Mattaparti S; Shulok T; Thacher T; Kong J; Kostrowicki J; Hu Q; Na J; Zhou JZ; Klatte D; Chao B; Ito S; Clark J; Sciammetta N; Coner B; Waller C; Kuki A
    Methods Mol Biol; 2011; 685():295-320. PubMed ID: 20981530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New potential antihistaminic compounds. Virtual combinatorial chemistry, computational screening, real synthesis, and pharmacological evaluation.
    Duart MJ; Antón-Fos GM; Alemán PA; Gay-Roig JB; González-Rosende ME; Gálvez J; García-Domenech R
    J Med Chem; 2005 Feb; 48(4):1260-4. PubMed ID: 15715494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the size of dynamic combinatorial libraries on the detectability of molecular recognition induced amplification.
    Ludlow RF; Otto S
    J Am Chem Soc; 2010 May; 132(17):5984-6. PubMed ID: 20392045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic library design.
    Huwe CM
    Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
    Piras P; Roussel C
    J Pharm Biomed Anal; 2008 Apr; 46(5):839-47. PubMed ID: 17942261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Array Design. A method for sampling combinatorial chemistry library space.
    Lipkin MJ; Rose VS; Wood J
    SAR QSAR Environ Res; 2002; 13(3-4):425-32. PubMed ID: 12184384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico fragment screening by replica generation (FSRG) method for fragment-based drug design.
    Fukunishi Y; Mashimo T; Orita M; Ohno K; Nakamura H
    J Chem Inf Model; 2009 Apr; 49(4):925-33. PubMed ID: 19354203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Customizable Generation of Synthetically Accessible, Local Chemical Subspaces.
    Pottel J; Moitessier N
    J Chem Inf Model; 2017 Mar; 57(3):454-467. PubMed ID: 28234470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OptiDock: virtual HTS of combinatorial libraries by efficient sampling of binding modes in product space.
    Sprous DG; Lowis DR; Leonard JM; Heritage T; Burkett SN; Baker DS; Clark RD
    J Comb Chem; 2004; 6(4):530-9. PubMed ID: 15244414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution-phase parallel synthesis of spirohydantoins.
    Nieto MJ; Philip AE; Poupaert JH; McCurdy CR
    J Comb Chem; 2005; 7(2):258-63. PubMed ID: 15762754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization.
    Hartenfeller M; Proschak E; Schüller A; Schneider G
    Chem Biol Drug Des; 2008 Jul; 72(1):16-26. PubMed ID: 18564216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategy for discovering chemical inhibitors of human cyclophilin a: focused library design, virtual screening, chemical synthesis and bioassay.
    Li J; Zhang J; Chen J; Luo X; Zhu W; Shen J; Liu H; Shen X; Jiang H
    J Comb Chem; 2006; 8(3):326-37. PubMed ID: 16677001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WinDock: structure-based drug discovery on Windows-based PCs.
    Hu Z; Southerland W
    J Comput Chem; 2007 Nov; 28(14):2347-51. PubMed ID: 17476686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico prediction of ionization constants of drugs.
    Lee PH; Ayyampalayam SN; Carreira LA; Shalaeva M; Bhattachar S; Coselmon R; Poole S; Gifford E; Lombardo F
    Mol Pharm; 2007; 4(4):498-512. PubMed ID: 17629304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial design of protein sequences with applications to lattice and real proteins.
    Bhattacherjee A; Biswas P
    J Chem Phys; 2009 Sep; 131(12):125101. PubMed ID: 19791919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.